Sagittarius Life Science Corp (TPEX:3205)

Sagittarius Life Science Revenue

Sagittarius Life Science had revenue of 147.12M TWD in the quarter ending March 31, 2026, with 45.75% growth. This brings the company's revenue in the last twelve months to 392.26M, down -13.15% year-over-year. In the year 2025, Sagittarius Life Science had annual revenue of 346.08M, down -26.01%.

• Revenue (ttm): 392.26M
• Revenue Growth: -13.15%
• P/S Ratio: 9.30
• Revenue / Employee: 3.50M
• Employees: 112
• Market Cap: 3.65B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	346.08M	-121.67M	-26.01%
Dec 31, 2024	467.75M	27.29M	6.20%
Dec 31, 2023	440.46M	-88.61M	-16.75%
Dec 31, 2022	529.07M	-58.55M	-9.96%
Dec 31, 2021	587.61M	29.43M	5.27%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error